Cipher Pharmaceuticals (TSE:CPH) has released an update.
Cipher Pharmaceuticals Inc. has recently strengthened its executive team by appointing Hamed Ghanei as the new Chief Business Officer, bringing over 15 years of specialty pharmaceuticals expertise and a proven track record in business development to the company’s growth strategy. The company, known for its diversified portfolio in dermatology and presence in North and South American markets, is poised for a significant growth phase with Ghanei’s extensive experience in licensing, M&A, and commercial product launches.
For further insights into TSE:CPH stock, check out TipRanks’ Stock Analysis page.
